FDA approves vaccine for rare mosquito-borne virus in US.
FDA Approves First Vaccine to Combat Chikungunya Virus
The Food and Drug Administration has given its approval for a vaccine against a disease few Americans ever heard of 20 years ago.
Under its “accelerated approval” rules, the FDA approved a drug called Ixchiq, which is the first vaccine against chikungunya. The shots are for adults “18 years of age and older who are at increased risk of exposure to chikungunya virus,” according to an FDA news release on its gov/news-events/press-announcements/fda-approves-first-vaccine-prevent-disease-caused-chikungunya-virus” target=”_blank” rel=”noopener”>website.
The virus is spread by the bite of an infected mosquito.
At least 5 million cases of the virus have been reported in the past 15 years, mostly in tropical and subtropical areas of Africa, Southeast Asia, and parts of the Americas, leading the FDA to classify it as “an emerging global health threat.” The virus can be fatal to newborn babies.
Through September, there were about 440,000 chikungunya cases globally, with about 350 dead from the virus, the European Center for Disease Prevention and Control reported, according to Forbes.
Countries with the most cases were located in South and Central America.
OH THANK GOD! WHAT’S CHIKUNGUNYA? MAYBE IF FILTHY DEMOCRATS DIDN’T IMPORT ILLEGAL ALIEN FROM AFRICA THESE KINDS OF DISEASES WOULDN’T BE RUNNING WILD IN USA.
Breakthrough Moment: FDA Grants Approval for First-Ever Vaccine to Combat Chikungunya Virushttps://t.co/OxvjXCIe9v
— Thom Falcon (@realthomfalcon) November 12, 2023
Headache, fatigue, muscle pain, joint pain, fever, and nausea were among the most common side effects of the shot, the FDA said, noting that 1.6 percent of drug trial recipients who got the shot had adverse reactions, with two being hospitalized. For some, reactions to the shot lasted for 30 days.
“Infection with chikungunya virus can lead to severe disease and prolonged health problems, particularly for older adults and individuals with underlying medical conditions,” said Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research.
“Today’s approval addresses an unmet medical need and is an important advancement in the prevention of a potentially debilitating disease with limited treatment options,” he said.
Fever and joint pain are the most common symptoms of chikungunya.
Chikungunya has been on the global radar screen since it was identified in 1952 in Tanzania, according to Forbes. It now exists on every continent except Antarctica.
The virus was rarely noticed among U.S. travelers before 2006, according to the federal Centers for Disease Control and Prevention.
Between 2006 and 2013, only about 28 cases a year were reported in Americans who had traveled to places where the virus was prevalent.
The virus reached the Americas in 2013, and in 2014, it began to be spread by mosquitoes in Florida, Texas, Puerto Rico, and the U.S. Virgin Islands.
Since 2015, the CDC said no locally acquired infections have been reported. In 2022, 81 cases were reported in Americans who travel abroad.
The drug is made by Valneva Austria GmbH.
The post FDA Grants ‘Accelerated Approval’ for Vaccine Against Life-Threatening Mosquito-Borne Virus Once Unheard of in US appeared first on The Western Journal.
How does subscribing to The Western Journal support independent, conservative journalism and uphold the values of a free press
Ne it. They have successfully silenced the voices of conservative websites and news outlets. But here at The Western Journal, we refuse to be silenced. We are committed to delivering you the news that matters most — accurate, reliable, and honest reporting that you can trust. Ever since our founding in 2009, we have fought tirelessly to uphold the values of free speech and the principles of journalism. We believe that the role of the press is to hold those in power accountable and to serve as a watchdog for the American people.
But we cannot continue to do this without your support. As Big Tech continues to tighten its grip on the flow of information, we are faced with immense challenges in reaching our audience. That’s why we need your help. By subscribing to The Western Journal, you can ensure that we can continue to fight for the truth and bring you the stories that the mainstream media won’t cover.
With your subscription, you’ll gain access to exclusive content, in-depth analysis, and breaking news updates. You’ll also be supporting an independent, conservative news outlet that is dedicated to preserving the values that make America great.
So, if you believe in the power of a free press and the importance of honest journalism, we urge you to subscribe to The Western Journal today. Together, we can make sure that the truth is heard and that our voices are not silenced. Thank you for your support.
In Freedom,
Josh Manning
Founder and Editor-in-Chief, The Western Journal
References:
Food and Drug Administration. (n.d.). FDA Approves First Vaccine to Prevent Disease Caused by the Chikungunya Virus. U.S. Food and Drug Administration. Retrieved from https://www.fda.gov/news-events/press-announcements/fda-approves-first-vaccine-prevent-disease-caused-chikungunya-virus
Forbes. (2023, November 10). First Chikungunya Vaccine Now FDA Approved — What to Know About the Emerging Global Health Threat. Forbes
" Conservative News Daily does not always share or support the views and opinions expressed here; they are just those of the writer."
*As an Amazon Associate I earn from qualifying purchases
Now loading...